Clinical trial
Islet Transplantation for Type 1 Diabetes
NCT00014911 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00014911 |
|---|---|
| Title | Islet Transplantation for Type 1 Diabetes |
| Official title | Islet Transplantation for Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression (ITN005CT) |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Immune Tolerance Network (ITN) |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Insulin-Dependent |
| Intervention type | Drug, Procedure |
| Interventions | Islet Transplantation, Sirolimus, Tacrolimus, Daclizumab, Sulfamethoxazole, Ganciclovir, Trimethoprim, Pentamidine |
| Enrollment | 36 |
| Start date | Apr 1, 2001 |
| Primary completion | Jun 1, 2005 |
| Completion | Aug 1, 2010 |
| First posted | Aug 31, 2001 |
| Last update posted | Mar 15, 2017 |
| Countries | Canada, Germany, Italy, Switzerland, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: